Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Segezha Group reported for 2024 according to RAS

4/28/25 SGZH

Artgen reported for 2024 by IFRS

4/28/25 ABIO

VTB resumes dividend payments

4/28/25 VTBR

INARCTICA reported for 3 months of 2025 by RAS

4/28/25 AQUA

Seligdar reports for 3 months of 2025 by RAS

4/28/25 SELG

Rosseti Siberia reported for 3 months of 2025 by RAS

4/28/25 MRKS

Magadanenergo reported for 3 months of 2025 according to RAS

4/28/25 MAGE

Delimobile has entered Yaroslavl

4/28/25 DELI

Henderson reported for 2024 by IFRS

4/28/25 HNFG

M.Video-Eldorado continues to renew its team

4/28/25 MVID